Newswise — Washington, DC (January 10, 2023) — Uptal D. Patel, MD, was announced today as Chair of the Kidney Health Initiative (KHI). In addition to starting the year with a new chairman, seven new members will also join KHI’s board of directors.
KHI is a public-private partnership between the American Society of Nephrology (ASN), the US Food and Drug Administration (FDA), and multisectoral member organizations to advance the development of safe and effective treatments for patients with kidney disease. The Board oversees KHI’s strategy and represents a diversity of 90 organizations that are members of the largest biomedical consortium in the kidney community, including researchers, industry, government, kidney patients and medical professionals. Dr. Patel joined his KHI board of directors in 2018 and has had a career spanning academia and the private sector. Dr. Patel received medical residency at the University of California, San Francisco, followed by a clinical fellowship in pediatric and adult nephrology, and at the University of Michigan, where he underwent a medical services research residency through the Robert Wood Johnson Clinical Scholars Program. Prior to joining industry in 2016, he was Associate Professor of Life Medicine and Pediatrics at Duke University; I was the director of research. Institute. He is an Adjunct Professor of Medicine at Duke University School of Medicine and is currently Head of the Clinical Nephrology Division and Executive Group for Early Cardiovascular, Renal and Metabolism at AstraZeneca where he is Director.
Incoming members of the Board of Directors are:
|
Jorge Serda, MD, MS, FASN St. Peter’s Healthcare Partners |
Bruce M. Robinson, MD, MS, FASN University of Michigan |
|
Manisha Dadania, MBA medtronic |
Glenda V. Roberts University of Washington |
|
Vanessa A. Evans Fresenius Medical Care |
Brigitte Schiller, MD, FASN
|
|
Amanda Grandinetti, MPH patient advocate |
“Our new board members hail from different areas of the kidney industry and add significant expertise, perspective and passion to KHI’s continued commitment to driving innovation in a pre-competitive environment. They will do it for us,” said Dr. Patel. We are grateful to have them on our board and look forward to working with their respective members as we continue our efforts to improve kidney health at KHI. ”
KHI sponsors projects, conferences, and educational activities aimed at removing barriers to the development of innovative renal therapeutics, medical devices, and biologics, contributing to FDA’s goals, and supporting federal policy. We have a broad portfolio. Promoting Kidney Health in America.
About ASNs
Since 1966, ASN has led the fight to prevent, treat and cure kidney disease.
Educate medical professionals and scientists, advance research and innovation,
Communicate new knowledge and advocate for the highest quality care for patients. ASNs are
Over 20,000 members representing 132 countries. For more information, see: www.asn-online.org and follow us Facebook, twitter, LinkedInWhen Instagram.
# # #
